Industry Solutions from Lexaria’s DehydraTECH™ Hemp and Cannabis Powders
February 13th, 2020
The cannabis industry across North America has had its share of growing pains, many of which are understandable in a newly emerging industry. But cannabis and CBD companies need to do a better job of putting their customers first. One way they can do this is to ensure that customers receive the quality and potency of product they expect – not some old inventory that has been sitting on warehouse shelves while its effectiveness degrades.
Thankfully it is not 1975 any longer – there are modern solutions cannabinoid suppliers can take to ensure their customers receive the very best. But consumers are going to have to demand it. There are three mains considerations: potency, safety, and financial.
Everything has a shelf life or a best before date – even you! Cannabinoids are no different. Its long been known that cannabinoids degrade over time. In a 2012 study conducted in Europe, active ingredients in various oils were examined over a 4-year time frame. In general, THC degraded and lost at an average rate of over 20% per year, for a total loss of 83.7% over 4 years when stored in chilled, dark conditions; and a total loss of 89.8% over 4 years when stored at room temperature in ambient light.
CBD tends to degrade at about one-half that rate, losing about 10% per year, for a total loss over the 4 years of 40.2% in dark, chilled conditions, or 44.8% under ambient light and temperature. (LINK)
As every long-term cannabis user knows, degradation of flower is more rapid, with most plant material turned into funky uselessness in less than a year – sometimes months. Molds or mildews can make old stored plant material a more serious problem, and microbial degradation is always possible in oils as well. It’s just a fact of life that microbial growth is generally more likely in a liquid environment than it is in dry conditions. Think of the contrasting environments of a small pond in the summer compared to dry desert sand, and you get the picture.
Regulators themselves do not yet agree on which contaminants might prove most dangerous to human health. Certainly they include Aspergillus, Salmonella and Escherichia coli as well as mycotoxins – all of which can exist within both dried cannabis and in cannabis oils. (LINK)
During 2019, two of North America’s largest cannabis companies announced multi-million-dollar losses on spoiled cannabis inventories. Billions of dollars were raised and spent to build the world’s largest cannabis grow facilities. Output from these enormous grow operations has yet to be maximized, but it is clear that supply is currently much larger than demand.
During the Fall of 2019, American farmers delivered the largest CBD crops in US history, leading to a glut of supply and plummeting prices for oils containing CBD. So, the million-dollar question is: what is going to happen to all this cannabis and hemp product?
Will this glut of supply lead to stale, degraded CBD and THC products in 2020 and 2021? Will consumers unknowingly be buying hopelessly old product that is 20% or 40% less potent than originally tested? Is there a concern of illness due to contaminants? Will cannabis companies be forced into additional write-downs of product that cost tens of millions of dollars? This is a looming nightmare for cannabis consumers and for an industry still emerging into a legal, regulated environment.
There are solutions – some of which have been known for years. Packaging that blocks light will help to slow down cannabinoid degradation. But this has to include packaging on the retail shelf – not just in industrial warehouses. That clear plastic bottle of “CBD water” sitting under bright lights in the retail store? Yeah…. probably not the best choice for delivering CBD to consumers!
Storing cannabinoids in chilled conditions – but not frozen – will also help deal with potency issues. Understanding the chemistry between the cannabinoids and the packaging that they are nestled within can be a huge determinant of potency and utility to consumers.
Some packaging actually reacts chemically with cannabinoids and in effect “absorbs” much of the cannabinoid into the actual package! It has been known at least since 1986 that some plastics absorb THC at alarming rates. (LINK) Frozen blood samples lost 60% to 100% of their THC when stored in polystyrene containers, vs. 0% loss when stored in glass. One can only imagine how much more aggressive this activity would be at room temperature. Did you know that many aluminum beverage cans are lined with an ultra thin layer of plastic?
Lexaria Bioscience Corp. has developed a technology that helps provide for more stable long-term storage of cannabinoid extracts intended for use in edible products today. It’s patented DehydraTECHTM technology and processing methodology, similar in some ways to a pasteurization technique, helps to reduce or eliminate microbiological growth and cannabinoid degradation. The elimination of even the tiniest fractions of “water activity” are generally “considered too dry for microbes to flourish and, thus, safe.” https://ehp.niehs.nih.gov/doi/full/10.1289/EHP5785
It turns cannabis and hemp oils into stabilized powders enabled with proprietary technology that enables faster and more effective absorption into the human bloodstream once ingested, but also greatly preserves the cannabinoids contained within and mitigates microbiological growth. In fact, long term storage of 2-3 years or more of cannabis oils with DehydraTECH is possible with reduced loss of cannabinoids compared to current industry practices.
Both the cannabis industry, and the CBD/hemp industry, now have the ability to manage their valuable inventories and reduce loss due to spoilage. Using DehydraTECH technology to extend the shelf life of inventories is very cost effective, and in many cases less expensive than an insurance policy.
And edible and topical products manufactured with DehyrdaTECH can help consumers enjoy superior experiences with proven delivery technology. In a landmark human clinical study, Lexaria proved that its DehydraTECH delivery technology produced 317% higher levels of CBD in the bloodstream in just 30 minutes, compared to an equal dose of generic CBD.
Fortunately for the industry and for consumers, Lexaria licenses its patented DehydraTECH technology to companies for use directly within their facilities and operations for all of their cannabis and/or hemp extract processing needs and also sells its patented DehydraTECH pre-processed CBD/hemp powders directly to manufacturers for use within their own products- both options for just pennies per serving.
It’s 2020: a new year and a new decade -thank goodness it is not 1975 any longer. Consumers should demand the latest technology and experiences from their cannabis product suppliers, and it is time for cannabis companies to treat their customers with the respect they deserve.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.